GLP-1 drugs , or glucagon-like peptide-1 compounds, represent a substantial shift in how we treat type 2 diabetes . These injectable therapies function to stimulating the body’s own GLP-1 hormone , which https://worldsocialindex.com/story6799324/glp-1-a-major-advance-in-diabetes-management